Prime medicine to present at upcoming investor conferences

Cambridge, mass., nov. 08, 2023 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated, one-time curative genetic therapies, today announced that company management will present at two upcoming investor conferences:
PRME Ratings Summary
PRME Quant Ranking